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Background: It is well known that enhanced production of reactive oxygen species (ROS) leads to oxidative stress
observed in atherosclerosis and that ROS can also cause damage in cellular macromolecules, including DNA.
Considering previous report that sildenafil, an inhibitor of phosphodiesterase 5 (PDE5), has antioxidant effects, in
the present study we evaluated the effect of this drug on genotoxicity of blood mononuclear cells (MNC) and liver
cells from atherosclerotic apolipoprotein E knockout mice (apoE-/-).
Methods: ROS production in MNC was evaluated by flow cytometry with the fluorescent dye dihydroethidium
(DHE), a method that has been used to quantify the production of superoxide anion, and DNA damage was
evaluated in both MNC and liver cells using the alkaline comet assay. Sildenafil-administered apoE-/- mice were
compared with strain-matched mice administered with vehicle and with C57BL/6 wild-type (WT) mice.
Results: MNC from apoE-/- vehicle exhibited a 2-fold increase in production of superoxide anion in comparison
with WT. In contrast, sildenafil-administered apoE-/- mice showed superoxide anion levels similar to those observed
in WT mice. Similarly, MNC and liver cells from apoE-/- vehicle mice showed a 4-fold and 2-fold augmented DNA
fragmentation compared with WT, respectively, and sildenafil-administered apoE-/- mice exhibited minimal DNA
damage in those cells similar to WT mice.
Conclusions: ApoE-/- mice chronically administered with sildenafil exhibited reduced levels of superoxide anion in
MNC and less DNA fragmentation in MNC and liver cells, which are biomarkers of genotoxicity. Therefore, sildenafil
may offer a new perspective to the use of PDE5 inhibitors to protect against DNA damage, in cells involved in the
inflammatory and dyslipidemic processes that accompany atherosclerosis.Background
Hypercholesterolemia and atherosclerosis results from
metabolic disorders, enhanced oxidative stress and inflam-
mation [1-3]. Experimentally, the apolipoprotein E knock-
out mouse (apoE-/-) has been widely used in studies
aiming to better understand this disease and to propose
new treatment approaches. In this model, the atheroscle-
rotic process increases continuously and the progression
of lesions is accelerated under Western-type diet [4-6].* Correspondence: evasquez@pq.cnpq.br
1Laboratory of Translational Physiology, Health Sciences Center, Federal
University of Espirito Santo (UFES), Vitoria, Brazil
2Pharmaceutical Sciences Graduate Program, University of Vila Velha (UVV),
Vila Velha, ES, Brazil
Full list of author information is available at the end of the article
© 2013 Rodrigues et al.; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the orExperimental and clinical evidences support the hy-
pothesis that lipid-oxidation products, obtained endo-
genously or ingested with food, increases incidence of
atherosclerosis [7-10] and even tumor frequency [8,9].
These effects are justified by genotoxicity in various locals,
including blood cells and hepatocytes [7]. Furthermore, it
has been suggested that the excessive generation of reactive
oxygen species (ROS), leading to the oxidative stress play
an important role in the induction of DNA damage [6,11].
Oxidative stress is the result of an imbalance between
the production of oxidant species and antioxidant de-
fences, with predominance of ROS [6,12]. High levels of
ROS are important mediators of damage in cell com-
ponents such as carbohydrates, lipids, proteins and
nucleic acids [13]. Oxidative damage to DNA can occurral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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strand breaks, leading to genomic instability and per-
manent changes in the genetic material (genotoxicity)
[14]. Thus, in conditions of increased oxidative stress, as
observed in atherosclerosis, antioxidant alternative strat-
egies could be convenient to reduce oxidative stress and
to prevent the genetic material damage. Experimentally,
the comet assay evaluates DNA damage, which is a bio-
marker of genotoxicity, in individual cells through the
measurement of DNA migration in gel electrophoresis
[15]. Although it has been usually performed in blood
cells, which are easily obtained to demonstrate systemic
genotoxic damage, other tissues can also be used, as the
effects of genotoxicity are tissue-specific [16,17]. Liver is
also considered a target organ for genotoxicity research,
specifically in atherosclerosis, as this is the main organ
of lipid metabolism [16,17].
Recently our laboratory showed that sildenafil, a phos-
phodiesterase 5 (PDE5) inhibitor which has been widely
used for erectile dysfunction and pulmonary hypertension
treatment [18,19], restores endothelial function in apoE-/-
mice [20]. Considering experimental evidence that this
drug can prevent oxidative stress induction and lipid
peroxidation [19,20], sildenafil could be a promising
pharmacological alternative to prevent ROS-induced
DNA damage in atherosclerosis. Therefore, the aim of
the present study was to evaluate the effect of sildenafil
on genotoxicity induced by oxidative stress of mono-




Table 1 summarizes average values of lipid profile in
wild-type (WT), apoE-/- vehicle and apoE-/- sildenafil. As
expected and consistent with classical and recent data
[20-26], the apoE-/- mice showed higher total plasma
cholesterol (12-fold), low density lipoproteins (LDL, 5-
fold), very low density lipoproteins plus intermediate
density lipoproteins (VLDL + IDL, 56-fold) and triglycer-
ides (5-fold) than the WT animals; the values of high
density lipoproteins (HDL) were significantly decreasedTable 1 Plasma Lipid profile
Parameters Groups
Wild-type apoE-/- vehicle apoE-/- sildenafil
Triglycerides (mg/dL) 52 ± 6.1 299 ± 47** 248 ± 52*
Total cholesterol (mg/dL) 100 ± 7.8 1229 ± 185** 1310 ± 222**
LDL (mg/dL) 34 ± 7.2 188 ± 49** 217 ± 48.6**
HDL (mg/dL) 49 ± 2.8 24 ± 8** 10 ± 0.9**
VLDL + IDL (mg/dL) 18 ± 5.5 1016 ± 195** 1083 ± 240**
Values are means ± SEM; 6-8 animals per group.
*p < 0.05 and **p < 0.01 vs. Wild-type group (ANOVA).(2-fold) compared with WT animals. Treatment with sil-
denafil did not change this lipid profile in apoE-/- mice.
Reactive oxygen species (ROS)
The term oxidative stress is often used to imply a con-
dition in which cells are exposed to excessive levels of ei-
ther molecular oxygen or chemical derivatives of oxygen
[27]. Our laboratory has previously shown the applicability
of the method of flow cytometry with dihidroethidium
(DHE) to evaluate the production of superoxide anions
in cells from the apoE-/- mouse [11]. The presence of
superoxide anions is indicated by the median fluores-
cence intensity (MFI, in a.u.). Typical histogram from
flow cytometric analysis show a rightward-shift in the
log of DHE fluorescence in apoE-/- vehicle (Figure 1A)
compared with WT, which contrasts with apoE-/- sil-
denafil. As expected, we observed in Figure 1B a re-
markable increase in the levels of superoxide anions in
apoE-/- vehicle mice (1629 ± 44 a.u., p < 0.01) compared
with WT mice (915 ± 124 a.u.) and treatment with sil-
denafil was able to decrease these levels in apoE-/- mice
(1065 ± 115 a.u., p < 0.01).
Analysis of DNA damage by comet assay
The genotoxicity analysis was performed by the alkaline
comet assay which measures single and double strand
breaks as well as lesions that are converted to strand break
by the alkaline pre-treatment (i.e., alkaline labile sites) [5].
In the comet assay, the percentage of DNA in the tail rep-
resents the number of fragments that migrated during
electrophoresis. Figures 2A and 3A represent typical
comets of MNC and liver cells (respectively), showing
higher DNA fragmentation in apoE-/- vehicle compared to
control WT, and that it was reduced in apoE-/- sildenafil.
Figure 2B shows the results of the average percent of
DNA in the tail of MNC (WT: 3.8 ± 0.4% vs. apoE-/- ve-
hicle: 6.0 ± 0.7%, p < 0.05 vs. apoE-/- sildenafil: 2.9 ± 0.3%,
p < 0.01). Similarly, Figure 3B shows the results of the
average percent of DNA in the tail of liver cells (WT: 5.5 ±
0.2% vs. apoE-/- vehicle: 9.0 ± 1.2%, p < 0.01 vs. apoE-/-
sildenafil: 6.4 ± 0.2%, p < 0.05). As shown, apoE-/- vehicle
group showed higher DNA damage when compared to
WT and it was demonstrated that apoE-/- mice adminis-
tered with sildenafil exhibit minimal DNA damage com-
parable with those observed in WT control mice.
Another parameter analyzed was the comet tail mo-
ment, an index of both the migration of the genetic
material and the relative amount of DNA in the tail
[28]. This analysis revealed a decrease of DNA fragmen-
tation in animals administered with sildenafil in both
MNC (Figure 2C: WT: 0.9 ± 0.2 a.u. vs. apoE-/- vehicle:
3.9 ± 0.7 a.u., p < 0.01 vs. apoE-/- sildenafil: 0.7 ± 0.2 a.u.,
p < 0.01) and liver cells (Figure 3C: WT: 2.1 ± 0.4 a.u. vs.
apoE-/- vehicle: 5.5 ± 1.0 a.u., p < 0.05 vs. apoE-/- sildenafil:
Figure 1 Effect of sildenafil treatment on superoxide anion
production in MNC of apoE-/- mice. (A) Representative histogram
from flow cytometric analysis using dihydroethidium (DHE) in
control C57 wild-type (WT), apoE-/- vehicle and apoE-/- sildenafil; the
log fluorescence (X axis) illustrates the intensity of fluorescence for
the number of cells counted (note the higher scales in the apoE-/-
vehicle histogram). A remarkable increase in the level of superoxide
anions was observed in apoE-/- vehicle. Line colors correspond to
bar colors below. (B) Bar graph showing mean fluorescence
intensity (MFI, in a.u.). The values are presented as means ± SEM; 6 to
8 animals per group. **p < 0.01, ANOVA).
Figure 2 Detection of DNA damage in MNC assessed by
alkaline comet assay. (A) Typical comets showing higher DNA
fragmentation in apoE-/- vehicle compared to control WT, which
contrasts with apoE-/- sildenafil; (B) Bar graph showing the mean of
percentage of DNA in tail; (C) Bar graph showing the mean of tail
moment (in a.u.); (D) Bar graph showing the mean of the number of
comets with moderate-to-high damage (more than 25% of DNA in
the tail). The values are presented as means ± SEM; 6 to 8 animals
per group. *p < 0.05 and **p < 0.01, ANOVA).
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the comets with moderate-to-high damage based on
the cutoff of more than 25% of DNA on the tail. This
parameter is summarized in the Figure 2D, which
shows that the number of comets with more than 25%
of DNA on the tail in MNC were significantly higher in
apoE-/- vehicle than in WT control mice (5.5 ± 1.2 vs.
0.8 ± 0.5, p < 0.01) and normalized in apoE-/- sildenafil
mice (0.7 ± 0.3, p < 0.01). Similar results were observed
in liver cells, as shown in Figure 3D (WT: 2.2 ± 0.7 vs.
apoE-/- vehicle: 6.8 ± 1.1, p < 0.01 vs. apoE-/- sildenafil:
2.0 ± 0.6, p < 0.01). Taken together, these results dem-
onstrate that chronic administration of sildenafil is able
to reduce DNA fragmentation in MNC and liver cells
of apoE-/- mice.
Discussion
Cumulative evidence suggests that DNA instability plays
an important role in chronic degenerative diseases as
atherosclerosis [29,30]. In this study, we reported for the
first time that chronic inhibition of PDE5 with sildenafilcan decrease genotoxicity in MNC and liver cells in vivo,
in atherosclerotic apoE-/- mouse model.
Interestingly, sildenafil did not change the plasma lipid
profile in apoE-/- mice, which is consistent with results
previously reported by our laboratory [20] and by others
[23]. Although Ronsein et al. [31] have proposed that
hypercholesterolemia directly contributes to the DNA
damage, which was also demonstrated in mice [11,17],
Figure 3 Detection of DNA damage in liver cells assessed by
alkaline comet assay. (A) Typical comets showing higher DNA
fragmentation in apoE-/- vehicle compared to control WT, which
contrasts with apoE-/- sildenafil; (B) Bar graph showing the mean of
percentage of DNA in tail; (C) Bar graph showing the mean of tail
moment (in a.u.); (D) Bar graph showing the mean of the number of
comets with moderate-to-high damage (more than 25% of DNA in
the tail). The values are presented as means ± SEM; 6 to 8 animals
per group. *p < 0.05 and **p < 0.01, ANOVA).
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evidence that the amelioration in oxidative stress and
DNA damage by sildenafil might be independent of
hypercholesterolemia.
Elevated levels of ROS, which is a characteristic of a state
of oxidative stress, has been reported in clinical and pre-
clinical studies in many cardiovascular diseases, including
diabetes, hypertension and atherosclerosis [3,11,24,34,35].
Although under physiological conditions ROS are con-
tinuously produced in most cells, the imbalance betweenROS production and its degradation, can lead to genomic
instability and, consequently, permanent changes in the
genetic material, contributing to unfavourable processes,
e.g. apoptosis, observed in different target tissues of the
cardiovascular diseases [17,36].
Oxidative DNA damage can result from a variety of fac-
tors including radiation, toxins, chemicals and ROS, by
products of normal metabolic processes [37]. It is well-
known that DNA damage can occur in cells exposed to
oxidative stress and the oxidative DNA damage has been
estimated as 104 hits per cell per day in humans; in this
way, oxidative stress could be the main contributor to
DNA damage in cardiovascular diseases [30,38,39].
Recently, we reported that sildenafil appears to involve
an enhancement of the nitric oxide (NO) pathway along
with a reduction in oxidative stress [20]. Moreover, it
has been shown that increased intracellular levels of
cGMP can inhibit NADPH oxidase expression/activity
[20,40,41], increase enzyme activities of superoxide
dismutase, catalase and glutathione peroxidase [19],
thereby reducing superoxide anion bioavailability. The
antioxidant properties of sildenafil [12] could constitute
a key mechanism for the decrease of oxidative stress
and DNA damage that we observed in MNC and liver
cells. Another potential advantage of a therapeutic
approach based on inhibition of PDE5 is that, unlike
strategies that attempt to increase NO levels (e.g., sub-
strates, co-factors, antioxidants) [42,43], this one avoids
risks associated with NO, which in excess is a cytotoxic
free radical which possess the characteristic of a “double-
edged sword” [44]. Accordingly, it has been demonstrated
that at high concentrations, NO leads to increases in the
production of peroxynitrite and oxidative stress [45], with
consequent DNA damage [46]. Finally, the beneficial
pleiotropic effects of sildenafil could also be explained,
by pharmacokinetic and pharmacodynamics characteris-
tics: high volume of distribution [47] and ubiquity of the
second-messenger target (cGMP) in cytoprotective signal-
ing pathways [48] distributed in various tissues/cells ex-
pressing PDE5 such as MNC [49] and liver cells [50-52].
Our findings are in agreement with recent studies in many
experimental models, which have demonstrated a pro-
tection of MNC [53] and prevention of liver injury by sil-
denafil through a direct contribution of the NO/cGMP
mechanism [52,54,55].
The comet assay used for analyses of DNA is a well-
established, simple, sensitive and extensively used tool to
evaluate genotoxicity by comet tail parameters that are
related to the amount of damage in nuclear DNA [56].
An advantage of this technique is the possibility of its
use in different cell types when it is suggested that the
genotoxicity is tissue specific [16,17]. Some authors
have suggested that comet pictures might be associated
with apoptotic cell nuclei, but they have limited this
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cells” that are easily recognizable in situ on the slides
[57,58]. Previous studies have shown that the apoptosis
could influence the parameters of the comet tail, but
not enough to distort the interpretation of the results
[58]. Additionally, the present study supports the idea
that the comet assay is a useful approach to assess the
efficacy in the treatment on genotoxicity of MNC and
liver cells, even in a short time interval (3 weeks).
The importance of evaluating MNC is based in the fact
that atherosclerosis is an inflammatory disease [3,25] that
causes an increase in recruitment of inflammatory leuko-
cytes, mainly the MNC types. Likewise, the liver was fo-
cused due to its metabolic importance and to its high
susceptibility to cumulative oxidized products of DNA
[17]. Furthermore, Folkmann et al. [17] showed that
dyslipidemic apoE-/- mice suffer from hepatic oxidative
stress/genotoxicity and this could be due to dysfunction of
the lipid metabolism. The novelty of the present study is
that it was possible to reduce DNA damage in MNC and
liver cells of apoE-/- mice by chronic inhibition of PDE5
with sildenafil, even under conditions of hypercholesterol-
emia, possibly by the same antioxidative mechanisms
above commented. This finding supports the idea that sil-
denafil is a promising novel pharmacologic strategy to
avoid tissue damage induced by oxidative stress as previ-
ously reported by us [20] and others [40,41,48], thus open-
ing the way for translational studies about the protection
of DNA in different clinical conditions.
Study strength and limitations
A major strength of our study is the evaluation of the
beneficial effects of sildenafil on genotoxicity in the
apoE-/- mouse, which exhibited a protective action
against DNA damage in MNC and liver cells. However,
this study has some limitations. Although it has been
demonstrated that sildenafil administered for 3 weeks
reduces oxidative stress in smoke induced erectile dys-
function in C57BL6 mice [59] and has been considered a
novel therapeutic strategy to repair the endothelial dys-
function in apoE-/- mice [20], we cannot predict whether
such beneficial effects on genotoxicity and oxidative
stress are long-lasting in atherosclerosis. Another limita-
tion of the present study is that we did not include in
our protocol a group of apoE-/- under a regular chow.
Conclusions
ApoE-/- mice are characterized by a systemic oxidative
stress, as demonstrated by MNC high levels of super-
oxide anion production that leads to DNA damage. In
these animals, hepatic oxidative stress (in terms of DNA
damage) is also substantial, when compared to control
normocholesterolemic animals. The treatment with sil-
denafil was efficient to decrease the levels of superoxideanion in MNC and the DNA fragmentation in both MNC
and liver cells in apoE-/- mice. Thus, we propose that sil-
denafil may offer a new perspective to the use of PDE5 in-
hibitors to protect against DNA damage observed in
atherosclerosis, independent of hypercholesterolemia.
Methods
Animals
Experiments were performed in male WT (C57BL6) and
apoE-/- mice obtained from the Laboratory of Trans-
genes in the Health Sciences Center at the Federal Uni-
versity of Espirito Santo, Brazil. Animals were housed in
individual plastic cages with a controlled temperature
(22-23°C) and humidity (60%) and were exposed to a
12:12-h light–dark cycle. All experimental procedures
were performed in accordance with the guidelines for
the care and handling of laboratory animals as recom-
mended by the National Institutes of Health (NIH), and
study protocols were previously approved by the Institu-
tional Animal Care and Use Committee (CEUA-Emescam,
Protocol 007/2010).
To accelerate and aggravate the spontaneous hyperlip-
idemia and atherosclerosis in apoE-/- mice, 8-week-old
animals were fed a Western-type diet (AIN93G modified
diet, Rhoster, Brazil). Animals were distributed into three
different groups: (a) apoE−/− mice administered with the
PDE5 inhibitor sildenafil (apoE−/− sildenafil, ViagraW,
40 mg/kg/day, for 3 weeks, by oral gavage), (b) apoE-/-
mice administered with vehicle and (c) WT control mice.
This dose of sildenafil has been previously used in
apoE-/- mice by Dussault et al. [23] and by our labora-
tory [20] in studies about endothelial dysfunction, based
on the fact that this drug has reduced oral bioavailability
by pre-systemic hepatic metabolism besides high clear-
ance in mice [60]. All animals had ad libitum access to
water and food during housing and treatment periods.
For each protocol were used 6 to 10 animals per group.
Samples
Animals were euthanized with sodium thiopental overdose
(100 mg/kg, IP). A thoracic incision was performed for
blood collection trough intra-cardiac puncture. Blood was
immediately transferred to a tube containing EDTA. Per-
ipheral blood mononuclear cells (MNC) were isolated by
HistopaqueW density gradient centrifugation, according to
the manufacturer’s instructions. The samples were stored
at -80°C until further analysis.
Liver cells enriched fractions from the mice liver of dif-
ferent groups were prepared as standardized in our labora-
tory based on previous studies [5,17]. The left lobe of the
liver was grossly triturated with surgical scissors and incu-
bated with an extraction solution containing proteinase K
(Sigma-Aldrich, St. Louis, MO, USA) and collagenase type
II (Gibco Life Technologies, São Paulo, SP, Brazil) to
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through a nylon screen (BD falcon 70 μm) to remove
cell debris. After, the samples were washed twice in
phosphate-buffered saline (PBS) to remove the enzymes.
The samples were stored at -80°C until further analysis.
Before performing analyzes of ROS production and
genotoxicity was carried out viability test through trypan
blue exclusion test and both MNC and liver cells showed
80–90% viability.
Measurement of lipid profile
The plasma of peripheral blood samples was used to
measurement of lipid profile, total plasma cholesterol,
HDL, LDL and triglycerides were determined using com-
mercial colorimetric assay kits (Bioclin, Belo Horizonte,
Brazil). VLDL and IDL were estimated by subtracting
HDL and LDL from total serum cholesterol.
Measurement of cytoplasmic reactive oxygen species
by DHE
DHE was used for the flow cytometry detection of intra-
cellular superoxide anion. DHE is freely permeable to
cells and is rapidly oxidized, mostly by superoxide, to
ethidium, which binds to DNA and amplifies red fluor-
escence signal. To estimate the content of superoxide
anion in cell suspension, 106 MNC were incubated with
20 μL of DHE (160 μM) for 30 min at 37°C in the dark
to load the cells with the dyes [11,35]. For positive con-
trol, samples were treated for 5 min with 50 μM H2O2
to create an oxidative stress without being toxic to the
cells. Cells were then washed, resuspended in PBS, and
kept on ice for an immediate detection by flow cyto-
metry (FACSCanto II, Becton Dickinson, San Juan, CA,
USA). Data was acquired and analyzed using the
FACSDiva software (Becton Dickinson, San Juan, CA,
USA). For quantification of DHE, samples were acquired
in triplicate and 10,000 events were used for each meas-
urement. Cells were excited at 488 nm and DHE was
detected using 585/42 bandpass filter and data expressed
as the median fluorescence intensity (MFI).
Measurement of oxidized DNA by alkaline comet assay
The DNA damage was assessed using alkaline single cell
gel electrophoresis (the alkaline comet assay), following
established protocols from our laboratory [11,26,35]
based on Singh et al. [15] with minor modifications and
under low brightness and controlled temperature due to
the photo and thermo sensitivity of the assay.
The comet assay is a well validated technique for mea-
surement of DNA damage in individual cells [56]. In brief,
histological slides were precoated with 1.5% normal mel-
ting point agarose in PBS in a water-bath at 65°C. Subse-
quently, 20 μL of cell suspension was embedded in 100 μL
of 0.5% low melting point agarose in PBS at 37°C andspread on agarose-precoated slides using coverslips. After
gelling at 4°C for 20 min, the coverslips were removed and
the slides were immersed in freshly prepared lysis solution
(2.5 M NaCl, 100 mM EDTA, 10 mM Tris, 34 mM N-
Lauroylsarcosine sodium, adjusted to pH 10.0-10.5, using
freshly added 1% Triton X-100 and 10% DMSO) for 1 hour
at 4°C. After washing in cold distilled water, the slides
were quickly immersed in PBS solution. Then, the slides
were placed in an electrophoresis chamber filled with
freshly prepared alkaline buffer (300 mM NaOH, 1 mM
EDTA, pH > 13) for 40 min at 4°C, and electrophoresed at
300 mA and 20 V for 30 min. Afterwards, the slides were
neutralized with a 0.4 M Tris buffer (pH 7.5), for 5 min,
washed with cold distilled water and allowed to dry at
room temperature for 1 hour.
Migration of DNA fragments towards the anode creates
a comet ‘tail’, visualized by staining with ethidium bromide
(20 μg/mL, Sigma-Aldrich). Immediately afterwards, im-
ages were obtained at a magnification of 20x using a fluor-
escence optical microscope (Nikon Eclipse TI, Melville,
NY, USA) equipped with excitation (510-550 nm) and bar-
rier (590 nm) filters. The coded images were acquired
using a CCD camera (Nikon) and were analyzed with
the CASP program (public domain). Among several pa-
rameters provided by the program CASP, we used the
percentage of DNA in the tail and the tail moment for
analysis of DNA damage. Comets with more than 25%
of tail DNA were categorized as moderate-to-high dam-
age and quantified. All samples were coded before sco-
ring. The images of 100 randomly selected cells from
each sample obtained from two replicate slides for each
animal were analyzed. During the image analysis, comets
without clearly identifiable heads or comets with most of
their DNA in their tails after electrophoresis were ex-
cluded, as a quality control parameter.
Statistical analysis
All data are expressed as the mean ± SEM. The
Kolmogorov-Smirnov test showed that variables had a
normal (Gaussian) distribution. The statistical analysis
was performed using the one-way analysis of variance
(ANOVA). When the ANOVA showed significant differ-
ences, the Bonferroni’s test was performed as a post hoc
analysis. The differences were considered significant
when p < 0.05.
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